Physician profile
Steven H Bailey
NPI 1083818926
$13,928.91
in general payments reported to CMS, 2019-2025
40 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,011 · 2020: $4,441 · 2021: $269 · 2022: $1,223 · 2023: $1,468 · 2024: $3,197 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,475 · Food and Beverage: $1,510 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,474.68 |
| Food and Beverage | $1,510.02 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $4,928.47 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Trimed, INC. | $1,805.79 | 2020 | |
| Allergan, INC. | $1,591.18 | 2019-2021 | |
| Abbott Laboratories | $1,433.25 | 2020 | |
| United Orthopedics LLC | $1,106.00 | 2020 | |
| Kci USA, INC. | $705.15 | 2019 | |
| Mentor Worldwide LLC | $540.75 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $406.31 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Trice Medical, INC. | $226.28 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $121.20 | 2019 | |
| Axogen | $110.85 | 2019-2025 | |
| Revance Therapeutics, INC. | $110.55 | 2024-2025 | Daxxify |
| Integra Lifesciences Corporation | $102.92 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries LP | $80.64 | 2021 | |
| Kerecis Limited | $56.15 | 2019-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.